[PHARMA] YoY TTM Result on 31-Mar-2009 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-May-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Mar-2009 [#1]
Profit Trend
QoQ- -6.7%
YoY- -10.47%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Revenue 1,582,398 1,446,116 1,304,640 1,309,712 1,237,398 1,063,349 959,313 8.69%
PBT 94,349 54,823 73,685 83,409 95,042 28,514 32,734 19.27%
Tax -28,102 -18,223 -17,340 -26,289 -30,835 -13,853 -9,671 19.43%
NP 66,247 36,600 56,345 57,120 64,207 14,661 23,063 19.20%
-
NP to SH 65,358 36,561 54,977 56,008 62,556 13,091 21,662 20.18%
-
Tax Rate 29.79% 33.24% 23.53% 31.52% 32.44% 48.58% 29.54% -
Total Cost 1,516,151 1,409,516 1,248,295 1,252,592 1,173,191 1,048,688 936,250 8.35%
-
Net Worth 474,161 437,661 439,675 402,378 367,905 321,111 335,032 5.95%
Dividend
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Div 44,120 50,261 97,382 48,140 35,295 12,310 14,388 20.51%
Div Payout % 67.51% 137.47% 177.13% 85.95% 56.42% 94.04% 66.42% -
Equity
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Net Worth 474,161 437,661 439,675 402,378 367,905 321,111 335,032 5.95%
NOSH 117,657 107,007 106,977 107,015 106,949 107,037 107,039 1.58%
Ratio Analysis
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
NP Margin 4.19% 2.53% 4.32% 4.36% 5.19% 1.38% 2.40% -
ROE 13.78% 8.35% 12.50% 13.92% 17.00% 4.08% 6.47% -
Per Share
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
RPS 1,344.91 1,351.41 1,219.55 1,223.85 1,157.00 993.44 896.23 6.99%
EPS 55.55 34.17 51.39 52.34 58.49 12.23 20.24 18.30%
DPS 37.50 47.00 91.00 45.00 33.00 11.50 13.44 18.63%
NAPS 4.03 4.09 4.11 3.76 3.44 3.00 3.13 4.29%
Adjusted Per Share Value based on latest NOSH - 107,015
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
RPS 109.80 100.34 90.52 90.87 85.86 73.78 66.56 8.69%
EPS 4.53 2.54 3.81 3.89 4.34 0.91 1.50 20.20%
DPS 3.06 3.49 6.76 3.34 2.45 0.85 1.00 20.47%
NAPS 0.329 0.3037 0.3051 0.2792 0.2553 0.2228 0.2325 5.95%
Price Multiplier on Financial Quarter End Date
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Date 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 31/03/06 -
Price 5.90 5.73 4.27 3.45 2.95 3.55 4.73 -
P/RPS 0.44 0.42 0.35 0.28 0.25 0.36 0.53 -3.05%
P/EPS 10.62 16.77 8.31 6.59 5.04 29.03 23.37 -12.30%
EY 9.42 5.96 12.04 15.17 19.83 3.45 4.28 14.03%
DY 6.36 8.20 21.31 13.04 11.19 3.24 2.84 14.36%
P/NAPS 1.46 1.40 1.04 0.92 0.86 1.18 1.51 -0.55%
Price Multiplier on Announcement Date
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Date 03/05/12 13/05/11 26/05/10 08/05/09 28/05/08 25/05/07 25/05/06 -
Price 5.90 5.05 4.71 3.82 3.45 3.45 4.53 -
P/RPS 0.44 0.37 0.39 0.31 0.30 0.35 0.51 -2.42%
P/EPS 10.62 14.78 9.16 7.30 5.90 28.21 22.38 -11.67%
EY 9.42 6.77 10.91 13.70 16.95 3.55 4.47 13.21%
DY 6.36 9.31 19.32 11.78 9.57 3.33 2.97 13.51%
P/NAPS 1.46 1.23 1.15 1.02 1.00 1.15 1.45 0.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment